D. Saleh

67 Limited-stage small cell lung cancer – how to address the high risk of intracranial metastases?

Small cell lung cancer (SCLC) accounts for approximately 15% of lung cancers and is characterised by rapid proliferation, early dissemination and poor prognosis. It has a strong predilection for brain metastases, with around 10% of patients presenting with intracranial disease. Current standard of care recommends...